RE:RE:RE:RE:yankee- you make a good pointI may be a "novice" of sorts to biotech, but I am a very experienced investor with 40 years of investing and 30 years as tax accounting.
The bean counters in big pharma are the same ones as any business with their risk tolerance. Sure some companies are more willing to take risks with not yet approved drugs but most of the enterprises I have invested in would rather pay a premium for a sure thing instead of paying less for a more risky venture. I certainly may be wrong and no, I do not expect to die within the next 8 months. I do indeed agree that the valuation would be huge with FDA approval. Furthermore I do my research yet I must sift through all the garbage that is put on the internet.